Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Syntrix Biosystems, Inc. v. Illumina Inc
Case Number:
3:10-cv-05870
Court:
Nature of Suit:
Judge:
Firms
- Bracewell LLP
- Buchalter APC
- Morrigan Law & Consulting
- Nix Patterson
- Northwest Resource Law
- Osborn Maledon
Companies
Sectors & Industries:
-
November 04, 2013
Illumina Can't Escape $115M Judgment In Syntrix Patent Suit
A Washington state federal judge on Monday refused to overturn a $115 million jury verdict in a patent infringement suit against Illumina Inc., finding Syntrix Biosystems had presented sufficient evidence that Illumina violated a patent covering DNA technology.
-
July 18, 2013
Illumina Seeks To Overturn $115M Award In Patent Row
Illumina Inc. told a Washington federal judge on Wednesday that a federal jury mistakenly found that it had infringed a patent covering DNA technology, resulting in a $115 million damages award to competitor Syntrix Biosystems Inc.
-
June 19, 2013
Judge Boosts Royalty Rate For Syntrix's Win in Patent Row
A Washington federal judge on Tuesday added to Syntrix Biosystems Inc.'s $115 million win in a suit alleging competitor Illumina Inc. infringed its patent covering DNA technology, finding the company was entitled to an 8 percent royalty for ongoing infringement.
-
May 03, 2013
Illumina Fails To Shred Syntrix DNA Patent After $96M Verdict
A Washington federal judge on Friday affirmed the validity of a Syntrix Biosystems Inc. patent covering DNA technology that a jury previously found was infringed by competitor Illumina Inc. as part of a $96 million verdict, ruling a claim construction in Syntrix's patent was "sufficiently clear".
-
March 14, 2013
Syntrix Wins $96M Verdict Against Illumina In DNA Patent Suit
A federal jury on Thursday returned a verdict for $96 million in favor of biotechnology research firm Syntrix Biosystems Inc., finding that Illumina Inc. has infringed and induced others to infringe a patent covering DNA technology held by Syntrix.